Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...
News Medical on MSN1d
A step toward precision medicine: New drug targets for heart failureA groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators Receive the the latest news, research, and ...
A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...
News Medical on MSN3d
University of Michigan tests novel mechanical heart pump in clinical trialA cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device ...
A recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, ...
The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...
Background The Prognostic Nutritional Index (PNI), calculated from serum albumin levels and lymphocyte counts, is a simple ...
The data are observational but intuitive, say experts. Further work might define where T-TEER’s greatest benefit lies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback